JAK3 inhibitors have demonstrated significant efficacy in treating rheumatoid arthritis by reducing inflammation and symptoms (Boyadzhieva et al., 2022; Chen et al., 2023; Sardana et al., 2023). Here, JAK3 is linked to rheumatoid arthritis.